Litcius/Paper detail

Bioprinting Decellularized Breast Tissue for the Development of Three-Dimensional Breast Cancer Models

Bárbara Blanco‐Fernandez, Sergi Rey-Viñolas, Gülsün Bağcı, Gerard Rubí-Sans, Jorge Otero, Daniel Navajas, Soledad Pérez‐Amodio, Elisabeth Engel

2022ACS Applied Materials & Interfaces75 citationsDOIOpen Access PDF

Abstract

The tumor extracellular matrix (ECM) plays a vital role in tumor progression and drug resistance. Previous studies have shown that breast tissue-derived matrices could be an important biomaterial to recreate the complexity of the tumor ECM. We have developed a method for decellularizing and delipidating a porcine breast tissue (TDM) compatible with hydrogel formation. The addition of gelatin methacrylamide and alginate allows this TDM to be bioprinted by itself with good printability, shape fidelity, and cytocompatibility. Furthermore, this bioink has been tuned to more closely recreate the breast tumor by incorporating collagen type I (Col1). Breast cancer cells (BCCs) proliferate in both TDM bioinks forming cell clusters and spheroids. The addition of Col1 improves the printability of the bioink as well as increases BCC proliferation and reduces doxorubicin sensitivity due to a downregulation of HSP90. TDM bioinks also allow a precise three-dimensional printing of scaffolds containing BCCs and stromal cells and could be used to fabricate artificial tumors. Taken together, we have proven that these novel bioinks are good candidates for biofabricating breast cancer models.

Topics & Concepts

GelatinExtracellular matrixMaterials scienceDecellularizationBreast cancerBiomedical engineeringTissue engineeringStromal cellCancer researchNanotechnologyCancerMedicineChemistryCell biologyBiologyInternal medicineBiochemistry3D Printing in Biomedical ResearchCancer Cells and MetastasisTissue Engineering and Regenerative Medicine
Bioprinting Decellularized Breast Tissue for the Development of Three-Dimensional Breast Cancer Models | Litcius